AstraZeneca beats Street EPS

AstraZeneca (LSE:AZN; AZN) reported third quarter EPS of $0.55, beating by $0.02 the Street's $0.53 estimate and up 19%

Read the full 197 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE